Stability and Storage: Why Peptides Degrade
The chemistry behind why peptide drugs lose potency or clump, which factors drive it, and why stability is a manufacturing and regulatory question, not a home-handling guide.
Content last updated . This page has not been medically reviewed.
Quick overview
A peptide medicine is only as good as the molecule that is still intact when it is used. Peptides can break down chemically, clump physically or become contaminated. This page explains the science of why, so that readers understand what regulators and manufacturers control. It is not a storage, mixing or handling guide, and nothing here can establish that any particular vial or product is safe or potent.Evidence labels used here: established for well-described chemistry from reviews, and insufficient evidence where no source was read.
Three kinds of instability
Chemical. A review of peptide and protein drugs in the solid state lists the main reactions: deamidation, peptide bond cleavage, oxidation, the Maillard reaction, beta-elimination and dimerization or aggregation. [1] A 2026 review adds that oxidation, deamidation, acylation and light-triggered reactions are particularly prominent in peptides, antibodies and antibody-drug conjugates. [2]Physical. Peptides can aggregate or precipitate. One review of long-acting peptides says these medicines have inherently poor physical and chemical stability, in addition to being broken down quickly by enzymes in the body. [3]
Microbiological. A review of cancer-medicine stability states that microbiological instability is a critical concern, especially for people with weakened immune systems, and ties it to sterility and endotoxin standards. [2] This was written for cancer medicines, so it supports the principle, not any claim about a specific peptide product.
What influences stability
For dry (lyophilized, or freeze-dried) forms, the review lists temperature, moisture, excipients (the other ingredients) and the physical state of the formulation, amorphous versus crystalline. [1] It also notes that reactions can occur even in the solid state, leading to degradation and inactivation. [1] Peptide and protein drugs are often formulated as dry solids to improve stability during storage, but the same review shows that dry does not mean unchangeable. [1] These are findings from a 1999 review, so they describe mechanisms rather than the behavior of any product on today's market.How a molecule can be designed for stability
Stability is also built into the molecule. The Ozempic label says semaglutide is modified at position 8 to protect it from the enzyme DPP-4. [4] That protects it inside the body, which is a separate matter from shelf life. See Lipidation, PEGylation and Cyclization. Enzyme breakdown in the body is covered in Enzymes and Peptide Breakdown.What this page does not tell you
It does not say how to store, mix or keep any product, how long a product lasts, or how to judge a product by sight. I did not use any source that supports such instructions, and the library does not provide home-testing guidance. For an approved medicine, the label and the dispensing pharmacist are the authority.Proper evidence not found: I looked for peer-reviewed stability data on specific unapproved "research" peptides sold online and found none I could read. For those products, stability is insufficient evidence, not "assumed fine."
Related guides
Frequently asked questions
Why do peptides degrade?
Common routes include oxidation, deamidation, bond cleavage and aggregation, influenced by temperature, moisture and other ingredients. [1]
Is a dry powder always stable?
No. Reactions can still occur in the solid state. [1]
Is stability the same as safety?
No. Microbiological contamination and endotoxin are separate concerns from chemical breakdown. [2]
Can a purity certificate prove a product is fine?
Not by itself. Purity is one property among several, and sterility and activity must be shown separately. [2] [3]
Where do the real storage rules come from?
From the approved product's label and regulatory file, not from general articles like this one.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Why this is a regulatory subject
- Stability data for one peptide do not transfer to another peptide or formulation. [1]
- A lab report of chemical purity does not by itself show sterility, absence of endotoxin or intact biological activity, because these are separate properties (see Peptide Safety: Adverse Events, Contamination and Injection Risks).
References
- Solid-state chemical stability of proteins and peptides (1999). Read 2026-10-22.
- Stability challenges of oncological medicines: The overlooked role of industrial pharmacy (2026). Read 2026-10-22.
- The industrial design, translation, and development strategies for long-acting peptide delivery (2022). Read 2026-10-22.
- OZEMPIC (semaglutide) injection, prescribing information, Novo Nordisk, DailyMed label published 2026-06-10. U.S. National Library of Medicine. Read 2026-10-22.